TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Mangoceuticals, Inc. ( (MGRX) ).
On May 2, 2025, Mangoceuticals, Inc. borrowed $100,000 from The Tiger Cub Trust, controlled by CEO Jacob D. Cohen, through a Promissory Note with an 18% annual interest rate, maturing by May 2, 2026, or upon a Qualified Financing event. The note includes terms for prepayment and default, with a mandatory prepayment clause triggered by a Qualified Financing. Additionally, on May 5, 2025, Mangoceuticals settled a lawsuit with 1800 Diagonal Lending, LLC by issuing 62,500 shares of restricted common stock, increasing its outstanding shares to 11,034,023.
More about Mangoceuticals, Inc.
Average Trading Volume: 284,004
Technical Sentiment Signal: Sell
Current Market Cap: $10.5M
See more data about MGRX stock on TipRanks’ Stock Analysis page.